Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment
International Journal of Molecular Sciences · 12.01.2023 · 24 (2) · 1511
DOI: 10.3390/ijms24021511 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.01.2023. Verfasst von Natasa Kustrimovic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Research on Autoimmune and Allergic Disease-CAAD, Università del Piemonte Orientale, 28100 Novara, Italy. Hauptthemen laut MEDLINE: Microbiota, Prostatic Neoplasms, Gastrointestinal Microbiome. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health-Grant Giovani Ricercatori 2019, Fondi di Ateneo per la Ricerca, University of Insubria.
Abstract (Originalsprache)
Growing evidence of the microbiome’s role in human health and disease has emerged since the creation of the Human Microbiome Project. Recent studies suggest that alterations in microbiota composition (dysbiosis) may play an essential role in the occurrence, development, and prognosis of prostate cancer (PCa), which remains the second most frequent male malignancy worldwide. Current advances in biological technologies, such as high-throughput sequencing, transcriptomics, and metabolomics, have enabled research on the gut, urinary, and intra-prostate microbiome signature and the correlation with local and systemic inflammation, host immunity response, and PCa progression. Several microbial species and their metabolites facilitate PCa insurgence through genotoxin-mediated mutagenesis or by driving tumor-promoting inflammation and dysfunctional immunosurveillance. However, the impact of the microbiome on PCa development, progression, and response to treatment is complex and needs to be fully understood. This review addresses the current knowledge on the host–microbe interaction and the risk of PCa, providing novel insights into the intraprostatic, gut, and urinary microbiome mechanisms leading to PCa carcinogenesis and treatment response. In this paper, we provide a detailed overview of diet changes, gut microbiome, and emerging therapeutic approaches related to the microbiome and PCa. Further investigation on the prostate-related microbiome and large-scale clinical trials testing the efficacy of microbiota modulation approaches may improve patient outcomes while fulfilling the literature gap of microbial–immune–cancer-cell mechanistic interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Translational Research on Autoimmune and Allergic Disease-CAAD, Università del Piemonte Orientale, 28100 Novara, Italy.
- Immunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy.
- Molecular Cardiology Laboratory, IRCCS-Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy.
ORCID-Profile: Lorenzo Mortara
Förderung
- Italian Ministry of Health-Grant Giovani Ricercatori 2019
- Fondi di Ateneo per la Ricerca
- University of Insubria
Zitieren
APA
Kustrimovic, N., Bombelli, R., Baci, D., & Mortara, L. (2023). Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment. International Journal of Molecular Sciences, 24(2), 1511. https://doi.org/10.3390/ijms24021511
Vancouver
Kustrimovic N, Bombelli R, Baci D, Mortara L. Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment. International Journal of Molecular Sciences. 2023;24(2):1511. doi:10.3390/ijms24021511
BibTeX
@article{Kustrimovic2023,
author = {Kustrimovic, Natasa and Bombelli, Raffaella and Baci, Denisa and Mortara, Lorenzo},
title = {Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {1511},
doi = {10.3390/ijms24021511}
}
EUVIMED